Yongbiao Huang
Overview
Explore the profile of Yongbiao Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yu C, Li L, Wang S, Xu Y, Wang L, Huang Y, et al.
Bioact Mater
. 2023 Apr;
25:430-444.
PMID: 37056270
Nanomaterials (NMs) have increasingly been used for the diagnosis and treatment of head and neck cancers (HNCs) over the past decade. HNCs can easily infiltrate surrounding tissues and form distant...
12.
Jin M, Liu B, Chen C, Huang Y, Zhang H, Chen B, et al.
Cancer Res
. 2023 Mar;
83(10):1742-1756.
PMID: 36939399
Significance: Analysis of sQTL reveals the role of genetically driven mRNA splicing alterations in NSCLC risk and elucidates that rs156697 variant impacts risk by altering GSTO2 splicing.
13.
Wang L, Chen X, Zhang L, Li L, Huang Y, Sun Y, et al.
Int J Med Sci
. 2023 Jan;
20(1):79-86.
PMID: 36619220
Artificial intelligence (AI) has been widely used in various medical fields, such as image diagnosis, pathological classification, selection of treatment schemes, and prognosis analysis. Especially in the image-aided diagnosis of...
14.
Wang Y, Huang Y, Yang M, Yu Y, Chen X, Ma L, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497433
Immunogenic cell death (ICD), a form of regulated cell death, is related to anticancer therapy. Due to the absence of widely accepted markers, characterizing ICD-related phenotypes across cancer types remained...
15.
Huang Y, Wang Y, Xu D, Xiao L, Qin W, Liu B, et al.
Front Genet
. 2022 Nov;
13:995736.
PMID: 36338984
Neuropilin-1 (NRP1) is a transmembrane protein involved in many physiological and pathological processes, and it functions as a co-receptor to facilitate the entry of SARS-CoV-2 into host cells. Therefore, it...
16.
Huang Y, Yuan Y, Chen S, Xu D, Xiao L, Wang X, et al.
Front Immunol
. 2022 Oct;
13:985781.
PMID: 36275701
Coronavirus disease 2019 (COVID-19) is a severe pandemic that has posed an unprecedented challenge to public health worldwide. Hepatocellular carcinoma (HCC) is a common digestive system malignancy, with high aggressiveness...
17.
Xiao L, Huang Y, Li Q, Wang S, Ma L, Fan Z, et al.
Front Mol Biosci
. 2022 Sep;
9:976878.
PMID: 36060239
This study aimed to develop a prognostic indicator based on epithelial-mesenchymal transition (EMT)-related long noncoding RNAs (lncRNAs) and explore the function of EMT-related lncRNAs in malignant progression in lung adenocarcinoma...
18.
Wang Y, Huang Y, Li C, Wang X, Yang M, Xu D, et al.
Front Cell Dev Biol
. 2022 Jul;
10:921320.
PMID: 35874811
Necroptosis, as a form of programmed cell death, is involved in many physiological and pathological processes. However, its role in cancer progression and therapeutic response remains controversial. Colon cancer is...
19.
Qin W, Zhao B, Wang D, Liu J, Zhou Y, Zhu W, et al.
Front Oncol
. 2022 Jul;
12:922342.
PMID: 35837092
Bevacizumab plus chemotherapy is a well-established first-line treatment for metastatic colorectal cancer (mCRC). We investigated whether polymorphisms of genes involved in immune regulation signaling are related to the clinical outcome...
20.
Huang S, Huang Y, Lin W, Wang L, Yang Y, Li P, et al.
Oxid Med Cell Longev
. 2022 May;
2022:2586305.
PMID: 35620578
Radiation-induced intestinal injury is a common and critical complication of radiotherapy for pelvic or abdominal tumors, with limited therapeutic strategies and effectiveness. Sitagliptin, a dipeptidyl peptidase IV (DPP4) inhibitor, has...